Pharmaceutical Manufacturer Invests $8.5 Million To Expand Its North Carolina Plant
01/03/2013
Exela Pharma Sciences develops and manufactures injectable and ophthalmic pharmaceutical products. The company currently employs more than 40 at its Lenoir facility.
“Exela is pleased to be in a position to pursue its expansion plans and create these high paying jobs in Caldwell County,” said Phanesh Koneru, Exela’s president and CEO. “Exela is thankful to the officials of the City of Lenoir, Caldwell County, and the State of North Carolina for their continued support of Exela’s business.”
According to Gov. Bev Perdue the project was made possible in part by an $189,000 grant from the One North Carolina Fund. “North Carolina has a proud and celebrated history in manufacturing,” said Gov. Perdue. “North Carolina’s biotech industry is thriving because of our highly-skilled workforce and strong business climate.”
The One NC Fund provides financial assistance, through local governments, to attract business projects that will stimulate economic activity and create new jobs in the state. Companies receive no money up front and must meet job creation and investment performance standards to qualify for grant funds. These grants also require and are contingent upon local matches.
Project Announcements
EPC-Columbia Plans Fremont, Ohio, Manufacturing Operations
11/05/2025
Aclara Resources Plans Calcasieu Parish, Louisiana, Heavy Rare Earth Separation Operations
11/04/2025
KCG Engineering Group Plans Chesapeake, Virginia, Operations
11/04/2025
Morin Establishes Little Rock, Arkansas, Operations
11/03/2025
Provalus Plans West Plains, Missouri, Operations
11/01/2025
Eos Energy Enterprises Expands Allegheny County, Pennsylvania, Operations
11/01/2025
Most Read
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025
-
The Compliance Reckoning Is Here
Q3 2025
-
Around the Horn: Data Center Supply Chains — What's Next?
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Rethinking Auto Site Strategy in the Age of Tariffs and Powertrain Shifts
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025